Further study revealed that the polypeptide PBN11-8 is able to disturb the FAK signaling, and abrogate cancer cell motility and invasiveness and antitumor protein may be a novel polypeptide for targeting FAK signaling. This evidence concerns the gene PTK2 and cancer.